MU Investments Company’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-358
Closed -$87K 179
2017
Q2
$87K Sell
358
-100
-22% -$23.5K 0.06% 42
2017
Q1
$110K Sell
458
-38
-8% -$8.85K 0.08% 43
2016
Q4
$103K Sell
496
-260
-34% -$53.9K 0.08% 46
2016
Q3
$174K Sell
756
-690
-48% -$169K 0.13% 42
2016
Q2
$333K Buy
+1,446
New +$333K 0.23% 40
2016
Q1
Sell
-1,246
Closed -$385K 195
2015
Q4
$385K Sell
1,246
-391
-24% -$116K 0.23% 64
2015
Q3
$413K Hold
1,637
0.22% 77
2015
Q2
$490K Buy
1,637
+950
+138% +$283K 0.23% 73
2015
Q1
$209K Buy
+687
New +$196K 0.1% 189

Other funds holding AGN

MU Investments Company's AGN Position: Q3 2017 in Review

MU Investments Company sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 358 shares — an estimated $87K sold.

MU Investments Company first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $490K in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • MU Investments Company reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • MU Investments Company sold 358 Allergan plc shares in Q3 2017, an estimated $87K.
  • MU Investments Company first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • MU Investments Company's Allergan plc position peaked at $490K in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on MU Investments Company's 13F filing for Q3 2017, filed 17 Oct 2017.